Home » Health »
Latest News »
New York Times »
NYT
» A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12-to-15-year-olds.
A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12-to-15-year-olds.
By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/33B3aS4
via IFTTT
0 Response to "A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12-to-15-year-olds."
Post a Comment